Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

8.26 (USD) • At close September 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 589.553559.224519.872509.023504.958490.653478.841478.01471.945466.413451.147443.009442.955450.534414.07411.276436.112417.16422.302366.003351.577355.223
Cost of Revenue 381.37375.666348.15349.324349.524347.711333.677330.746316.69321.948322.372308.426303.95305.708289.68271.534289.523285.477296.087251.873244.948247.682
Gross Profit 208.183183.558171.722159.699155.434142.942145.164147.264155.255144.465128.775134.583139.005144.826124.39139.742146.589131.683126.215114.13106.629107.541
Gross Profit Ratio 0.3530.3280.330.3140.3080.2910.3030.3080.3290.310.2850.3040.3140.3210.30.340.3360.3160.2990.3120.3030.303
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 122.53128.503102.614118.075116.359117.179107.251117.96891.255119.782110.679119.395121.676125.31106.633114.243110.12196.77199.2892.13477.86985.491
Selling & Marketing Expenses 0018.340-0.22405.019002.86103.3623.524000000000
SG&A 127.624128.503120.954118.075116.135117.179112.27117.96891.255122.643110.679122.757125.2125.31106.633114.243110.12196.77199.2892.13477.86985.491
Other Expenses 0.1513.2544.9977.60.0915.8090.561105.64825.1694.18317.3850-0.0015.6491.1270.0550.0010.159-0.205-0.110.0141.791
Operating Expenses 127.775131.757125.951125.675116.226122.988112.831223.616117.795126.826128.064105.161116.32130.959111.683119.388115.291101.619103.60496.74382.6989.674
Operating Income 80.40851.80145.77134.02437.12622.86629.293-76.35237.49217.639-1.7584.78722.68513.776-113.04818.34730.29428.29617.72612.877-51.95717.867
Operating Income Ratio 0.1360.0930.0880.0670.0740.0470.061-0.160.0790.038-0.0040.0110.0510.031-0.2730.0450.0690.0680.0420.035-0.1480.05
Total Other Income Expenses Net -36.27-41.653-18.836-61.356-33.147-21.376-60.888-25.406-12.703-48.071-34.68516.842-17.8514.155-9.064-17.357-28.855-22.189-25.057-20.75-23.34120.901
Income Before Tax 44.13810.14826.935-27.3323.9791.49-31.595-101.75824.789-30.432-239.14321.629-474.23127.931-122.1120.991.4396.107-7.331-7.873-75.29838.768
Income Before Tax Ratio 0.0750.0180.052-0.0540.0080.003-0.066-0.2130.053-0.065-0.530.049-1.0710.062-0.2950.0020.0030.015-0.017-0.022-0.2140.109
Income Tax Expense 17.113-4.955-2.24515.511-9.92712.662-5.8590.631-0.811.566-1.3642.669-0.3442.5974.08-1.10.1790.3092.401-0.4712.2551.131
Net Income 27.0255.19329.18-42.84313.906-11.172-25.736-102.38925.599-31.998-237.77924.298-473.88725.334-126.1922.091.265.798-9.732-7.402-77.55337.637
Net Income Ratio 0.0460.0090.056-0.0840.028-0.023-0.054-0.2140.054-0.069-0.5270.055-1.070.056-0.3050.0050.0030.014-0.023-0.02-0.2210.106
EPS 0.130.0270.15-0.220.072-0.058-0.13-0.540.14-0.17-1.280.13-2.560.14-0.680.010.010.032-0.068-0.041-0.430.21
EPS Diluted 0.130.0250.14-0.220.071-0.058-0.13-0.540.13-0.17-1.280.13-2.560.14-0.670.010.010.032-0.068-0.041-0.430.21
EBITDA 87.1153.42972.23519.26151.05950.28215.223-54.88170.20321.75-195.8489.704-441.06560.307-97.8320.06936.46838.69824.58124.692-48.81467.137
EBITDA Ratio 0.1480.0960.1390.0380.1010.1020.032-0.1150.1490.047-0.4340.022-0.9960.134-0.2360.0490.0840.0930.0580.067-0.1390.189